September 2020 – PHAGElogist

Tracking the Global Pipeline of Antibiotics in Development

Drug-resistant bacteria, or superbugs, present a serious and worsening threat to human health. According to a report from the Centers for Disease Control and Prevention, 2.8 million Americans acquire serious infections caused…

Gold Chance for Bacteriophage Researchers: Journal Publication

Antibiotics (mdpi publisher) In light of your outstanding expertise, we would like to cordially invite you to contribute a paper to be included in the Special Issue “Phage Therapy to Control…

Treating Covid-19 may lead to increased antibiotic resistance

Patients hospitalised due to the novel coronavirus infection are being given a combination of medications to prevent possible secondary bacterial infections, noted the researchers at the University of Plymouth in…

Researchers Advance the Fight Against Antibiotic Resistance

Each year, about 2.8 million Americans get bacterial infections that resist treatment by the antibiotics designed to knock them out. About 35,000 of those patients die – globally the mortality…

Intravesical bacteriophages for treating urinary tract infections

Published in the Lancet Infectious Diseases Background Urinary tract infections (UTIs) are among the most prevalent microbial diseases and their financial burden on society is substantial. In the context of…

Bacteriophages could combat secondary COVID-19 infections

New research suggests that bacteriophage therapy could counteract the risk of secondary bacterial infections, which affect some patients with weakened immune systems after being infected with the SARS-CoV-2 coronavirus.A study…

Phage Therapy- Where are we now?

Phage therapy research in the West has accelerated in recent years. In practical terms, treatment options remain reserved for compassionate cases — but of the 29 such cases reported since…